Short tandem repeats or microsatellites can present a pathogenic function in the presence of certain mutations, deaminations or copy number increases. Repeats of the sequence ATTTC have been shown to cause certain types of spinocerebellar ataxia (SCA) and familial adult myoclonic epilepsy (FAME). Multiple repeats of ATTTC in intronic regions of some genes lead to alternative splicing and the formation of protein isoforms, which can cause pathogenic activity due to their change in function. Short tandem repeats are of interest because their ability to form noncanonical structures. During the diploma thesis our research interests were focused in sequence d(ATTTC)3, DNA oligonucleotide denominated EP3, for which preliminary studies have shown that it forms a noncanonical structure in the presence of Ca2+ or Mg2+ ions in solution. We expanded on the knowledge gathered from previous studies by testing whether the same structure is formed due to the presence of Zn2+ ions to try to better understand the meaning and role of the divalent ions needed for the formation of the structure. Using 1D 1H NMR experiments we determined the effect of pH, temperature, and the presence of buffer along with the type and concentration of the divalent ions. We performed structural characterization of EP3 structure formed in the presence of Zn2+ with the use of 1D 1H and 2D 1H-1H NOESY experiments and compared it with the already known structure which is formed in the presence of Mg2+ ions and concluded that the structure is identical at least in the range of ionic radii 0,72–1,00 Å. We showed that the structure forms at least in the pH range from 3,5 to 6,0 and at temperatures of up to 10 °C. With further increases in temperature EP3 is predominantly in the unfolded form. The presence of potassium phosphate buffer in solution also doesn't affect the formation of the noncanonical structure. Knowing the structure and the conditions of its formation could offer an insight into the formation of certain pathogenic states and the identification of potential ways of treatment for neuredegenerative diseases in which ATTTC repeats are present.
|